Carbamoylphosphonate matrix metalloproteinase inhibitors 6: cis-2-aminocyclohexylcarbamoylphosphonic acid, a novel orally active antimetastatic matrix metalloproteinase-2 selective inhibitor--synthesis and pharmacodynamic and pharmacokinetic analysis.

@article{Hoffman2008CarbamoylphosphonateMM,
  title={Carbamoylphosphonate matrix metalloproteinase inhibitors 6: cis-2-aminocyclohexylcarbamoylphosphonic acid, a novel orally active antimetastatic matrix metalloproteinase-2 selective inhibitor--synthesis and pharmacodynamic and pharmacokinetic analysis.},
  author={A. Hoffman and Bashir Qadri and Julia Frant and Yiffat Katz and S. R. Bhusare and E. Breuer and R. Hadar and R. Reich},
  journal={Journal of medicinal chemistry},
  year={2008},
  volume={51 5},
  pages={
          1406-14
        }
}
  • A. Hoffman, Bashir Qadri, +5 authors R. Reich
  • Published 2008
  • Chemistry, Medicine
  • Journal of medicinal chemistry
  • cis-2-Aminocyclohexylcarbamoylphosphonic acid ( cis-ACCP) was evaluated in vitro and in two in vivo cancer metastasis models. It reduced metastasis formation in mice by approximately 90% when administered by a repetitive once daily dosing regimen of 50 mg/kg via oral or intraperitoneal routes and was nontoxic up to 500 mg/kg, following intraperitoneal administration daily for two weeks. Pharmacokinetic investigation of cis-ACCP in rats revealed distribution restricted into the extracellular… CONTINUE READING
    33 Citations
    Aminoalkylcarbamoylphosphonates reduce TNFα release from activated immune cells.
    • 5
    Dual targeting of cancer-related human matrix metalloproteinases and carbonic anhydrases by chiral N-(biarylsulfonyl)-phosphonic acids
    • 5
    • PDF

    References

    SHOWING 1-10 OF 31 REFERENCES
    Pharmacodynamic and pharmacokinetic rationales for the development of an oral controlled-release amoxicillin dosage form.
    • 37
    Phase I clinical trial of oral COL-3, a matrix metalloproteinase inhibitor, in patients with refractory metastatic cancer.
    • M. Rudek, W. Figg, +7 authors E. Reed
    • Medicine
    • Journal of clinical oncology : official journal of the American Society of Clinical Oncology
    • 2001
    • 148